Pending AI
The AI engine Fit Assessment
BetaPending.AI effectively utilizes machine learning to enhance drug discovery, pattern discovery, and the development of new therapeutics.
Blurb
Artificial intelligence- and quantum mechanics-based capabilities to Design, Make, Test, and Analyse novel pharmaceuticals.
HQ Location
Cambridge (United States)
Founded
2018
Employees
1 - 10
Total funding raised
Not available
Funding Status
Venture - Series Unknown, January 1, 2021
Subspaces
- Drug Discovery Optimization
Developer of a computational drug discovery platform designed to support the creation of new medicines. The company offers quantum mechanical protein modeling and artificial intelligence-guided compound design, enabling pharmaceutical researchers improved target understanding and earlier identification of viable drug candidates.